Work

Phase 1 Study of MK-5475, an Inhaled Soluble Guanylate Cyclase Stimulator, in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD)

Year: 2023

Type: conference-abstract

Source: American Journal of Respiratory and Critical Care Medicine

DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1183

Authors: E. Bajwa, D. Cislak, A. Kumar, D. Li, E.J. Messina, T. Reynders, J.-F. Denef, V. Corcea, E. Lai, S.A. Stoch

Institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), MSD (Belgium), MSD (Belgium)

Language: English

Topic: Pulmonary Hypertension Research and Treatments

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4367599532

Cites:

Cited by:

Related to: 10